Complement activation in patients with neuromyelitis optica.

Complement activation in patients with neuromyelitis optica.

Показать другие версии (1)

The role of complement has been demonstrated in experimental models of neuromyelitis optica (NMO), however, only few studies have analysed complement components longitudinally in NMO patients. We measured serum or plasma concentrations of anti-C1q antibodies and complement split products C3a and C4a...

Полное описание

Библиографические подробности
Главные авторы:	Nytrova, P, Potlukova, E, Kemlink, D, Woodhall, M, Horakova, D, Waters, P, Havrdova, E, Zivorova, D, Vincent, A, Trendelenburg, M
Формат:	Journal article
Язык:	English
Опубликовано:	2014

Схожие документы

Complement activation in patients with neuromyelitis optica
по: Nytrova, P, и др.
Опубликовано: (2014)

C3a complement split product: possible biomarker of disease activity in patients with neuromyelitis optica
по: Nytrova, P, и др.
Опубликовано: (2013)

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
по: Saadoun, S, и др.
Опубликовано: (2010)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
по: Waters, P, и др.
Опубликовано: (2016)

IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica
по: Jacob, S, и др.
Опубликовано: (2008)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
по: Kitley, J, и др.
Опубликовано: (2012)

Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
по: Woodhall, M, и др.
Опубликовано: (2013)

Immunological insights into the mechanisms by which RTX is effective in Neuromyelitis Optica spectrum disorders
по: Damato, V, и др.
Опубликовано: (2019)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
по: Nour, M, и др.
Опубликовано: (2014)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
по: Kitley, J, и др.
Опубликовано: (2013)

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
по: Absoud, M, и др.
Опубликовано: (2014)

Neuromyelitis optica relapses: race and rate, immunosuppression and impairment
по: Tackley, G, и др.
Опубликовано: (2016)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
по: Kitley, J, и др.
Опубликовано: (2011)

Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies
по: Cavus, F, и др.
Опубликовано: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
по: Kitley, J, и др.
Опубликовано: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
по: Kitley, J, и др.
Опубликовано: (2013)

Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
по: Min, J, и др.
Опубликовано: (2013)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
по: Jarius, S, и др.
Опубликовано: (2008)

IgG subclasses of disease-specific antibodies and complement activation in vitro in myasthenia gravis and neuromyelitis optica
по: Jacob, S, и др.
Опубликовано: (2007)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
по: Kitley, J, и др.
Опубликовано: (2013)

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
по: Kim, S, и др.
Опубликовано: (2013)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
по: Waters, P, и др.
Опубликовано: (2015)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
по: Jarius, S, и др.
Опубликовано: (2008)

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
по: Mader Simone, и др.
Опубликовано: (2011-12-01)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
по: Viegas, S, и др.
Опубликовано: (2009)

MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY AS A CAUSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH A NEUROMYELITIS OPTICA-LIKE PHENOTYPE IN ADULTS
по: Kitley, J, и др.
Опубликовано: (2012)

Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
по: Akman-Demir, G, и др.
Опубликовано: (2011)

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
по: Waters, P, и др.
Опубликовано: (2008)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
по: Collongues, N, и др.
Опубликовано: (2013)

Neuromyelitis Optica
по: Goyal V, и др.
Опубликовано: (2009-10-01)

Neuromyelitis optica
по: Jacob Anu, и др.
Опубликовано: (2007-01-01)

Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain
по: Saadoun, S, и др.
Опубликовано: (2013)

Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders
по: Katsuichi Miyamoto, и др.
Опубликовано: (2023-03-01)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
по: Kitley, J, и др.
Опубликовано: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
по: Kitley, J, и др.
Опубликовано: (2014)

Neuromyelitis optica IgG causes placental inflammation and fetal death.
по: Saadoun, S, и др.
Опубликовано: (2013)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
по: Sato, D, и др.
Опубликовано: (2014)

Sex bias in multiple sclerosis and neuromyelitis optica spectrum disorders: How it influences clinical course, MRI parameters and prognosis
по: Petra Nytrova, и др.
Опубликовано: (2022-08-01)

Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders
по: Damato, V, и др.
Опубликовано: (2022)

Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica
по: Kim, B, и др.
Опубликовано: (2010)